Cargene is a preclinical-stage biopharmaceutical company developing oligonucleotide therapeutics across a broad range of diseases and targeting a variety of organs and tissues.
With sites in Singapore, China and USA, Cargene leverages our chemistry and biological insights to deliver clinically meaningful treatments.
Cargene was founded by experienced biotech entrepreneurs XQ Lin, Dr. Yann Chong Tan, Professor Torsten Wuestefeld, and is advised by a world-class SAB including Professors Harvey Lodish, Roger Foo and Kosh Ray.
Location: Singapore
Member count: 11-50
Total raised: $19.2M
Investors 1
| Date | Name | Website |
| - | EVX Ventur... | evx.ventur... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 15.12.2021 | Series A | $19.2M | BioTrack C... | en.prnasia... |
Mentions in press and media 3
| Date | Title | Description | Category | Author | Source |
| 15.12.2021 | Cargene Bi... | Cargene Biopharma, a Singapore... | China Sin... | - | finsmes.co... |
| 14.12.2021 | Cargene Cl... | SINGAPORE and SHANGHAI and BOS... | - | - | marketscre... |
| 14.12.2021 | Cargene Cl... | SINGAPORE and SHANGHAI and BOS... | - | - | en.prnasia... |